FCER2 and B-cell chronic lymphocytic leukemia: The immunological profile of CLL is now well defined: monoclonal B-cell lymphocytes co-expressing CD5 and CD23, with a low expression of CD20 and CD22, and low surface immunoglobulin (Ig) expression [4].